Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heidi T May

Showing results (91-100 of 153) with videos related to

Pageof 16
Sort By:
The American Journal of Cardiology|March 10, 2009
Relation of bisphosphonate therapies and risk of developing atrial fibrillationT Jared Bunch, Jeffrey L Anderson, Heidi T May, et al.
The American Journal of Cardiology|September 10, 2018
The Impact of Gender on Atrial Fibrillation Incidence and Progression to DementiaAnjani Golive, Heidi T May, Tami L Bair, et al.
Physiological Reports|February 13, 2021
Vitamin D supplementation protects against reductions in plasma 25-hydroxyvitamin D induced by open-heart surgery: Assess-d trialTyler Barker, Heidi T May, John R Doty, et al.
Heart Rhythm|December 17, 2013
Patients treated with catheter ablation for ventricular tachycardia after an ICD shock have lower long-term rates of death and heart failure hospitalization than do patients treated with medical management onlyT Jared Bunch, J Peter Weiss, Brian G Crandall, et al.
Journal of Cardiovascular Electrophysiology|October 8, 2015
The Impact of Age on 5-Year Outcomes After Atrial Fibrillation Catheter AblationT Jared Bunch, Heidi T May, Tami L Bair, et al.
Journal of Atrial Fibrillation|August 7, 2019
The Impact of Repeated Cardioversions for Atrial Fibrillation on Stroke, Hospitalizations, and Catheter Ablation OutcomesVictoria Jacobs, Heidi T May, Tami L Bair, et al.
European Heart Journal|August 30, 2020
Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trialMatthew J Budoff, Deepak L Bhatt, April Kinninger, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|May 22, 2016
Long-term influence of body mass index on cardiovascular events after atrial fibrillation ablationT Jared Bunch, Heidi T May, Tami L Bair, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|September 21, 2021
Absent or Mild Coronary Calcium Predicts Low-Risk Stress Test Results and Outcomes in Patients Considered for Flecainide TherapyJeffrey L Anderson, Stacey Knight, Raymond O McCubrey, et al.
Heart Rhythm|July 13, 2019
Stroke and dementia risk in patients with and without atrial fibrillation and carotid arterial diseaseT Jared Bunch, Tami L Bair, Brian G Crandall, et al.
Pageof 16

Showing results (91-100 of 153) with videos related to

Sort By:
Pageof 16
The American Journal of Cardiology|March 10, 2009
Relation of bisphosphonate therapies and risk of developing atrial fibrillationT Jared Bunch, Jeffrey L Anderson, Heidi T May, et al.
The American Journal of Cardiology|September 10, 2018
The Impact of Gender on Atrial Fibrillation Incidence and Progression to DementiaAnjani Golive, Heidi T May, Tami L Bair, et al.
Physiological Reports|February 13, 2021
Vitamin D supplementation protects against reductions in plasma 25-hydroxyvitamin D induced by open-heart surgery: Assess-d trialTyler Barker, Heidi T May, John R Doty, et al.
Heart Rhythm|December 17, 2013
Patients treated with catheter ablation for ventricular tachycardia after an ICD shock have lower long-term rates of death and heart failure hospitalization than do patients treated with medical management onlyT Jared Bunch, J Peter Weiss, Brian G Crandall, et al.
Journal of Cardiovascular Electrophysiology|October 8, 2015
The Impact of Age on 5-Year Outcomes After Atrial Fibrillation Catheter AblationT Jared Bunch, Heidi T May, Tami L Bair, et al.
Journal of Atrial Fibrillation|August 7, 2019
The Impact of Repeated Cardioversions for Atrial Fibrillation on Stroke, Hospitalizations, and Catheter Ablation OutcomesVictoria Jacobs, Heidi T May, Tami L Bair, et al.
European Heart Journal|August 30, 2020
Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trialMatthew J Budoff, Deepak L Bhatt, April Kinninger, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|May 22, 2016
Long-term influence of body mass index on cardiovascular events after atrial fibrillation ablationT Jared Bunch, Heidi T May, Tami L Bair, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|September 21, 2021
Absent or Mild Coronary Calcium Predicts Low-Risk Stress Test Results and Outcomes in Patients Considered for Flecainide TherapyJeffrey L Anderson, Stacey Knight, Raymond O McCubrey, et al.
Heart Rhythm|July 13, 2019
Stroke and dementia risk in patients with and without atrial fibrillation and carotid arterial diseaseT Jared Bunch, Tami L Bair, Brian G Crandall, et al.
Pageof 16